871952469	871952469	CD	B-NP	O
|	|	NNP	I-NP	O
RH	RH	NNP	I-NP	O
|	|	VBD	B-VP	O
44125464	44125464	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1647987	1647987	CD	B-NP	O
|	|	CC	I-NP	O
5/24/2002	5/24/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
shortnes	shortne	NNS	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
not	not	RB	B-NP	O
cardiac	cardiac	JJ	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/24/2002	5/24/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/9/2002	2/9/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
KIMERY	KIMERY	NN	B-NP	O
,	,	,	O	O
BRADY	BRADY	NN	B-NP	O
469-14-25-6	469-14-25-6	CD	I-NP	O
Prings	Prings	NNP	I-NP	O
Sa	Sa	NNP	I-NP	O
Bockyonkers	Bockyonkers	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/11/02	1/11/02	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FEIGENBAUM	FEIGENBAUM	NNP	B-NP	O
,	,	,	O	O
MILLARD	MILLARD	NNP	B-NP	O
ERVIN	ERVIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
650	650	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
headache	headache	NN	I-NP	O
ECASA	ECASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/9	7/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
N	N	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
34	34	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
qAM	qAM	NN	I-NP	O
;	;	:	O	O
36	36	CD	B-NP	O
UNITS	UNITS	NNS	I-NP	O
qPM	qPM	NN	I-NP	B-DNA
SC	SC	NN	I-NP	I-DNA
34	34	CD	B-NP	I-DNA
UNITS	UNITS	NNS	I-NP	I-DNA
qAM	qAM	NN	B-NP	I-DNA
36	36	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
qPM	qPM	NN	I-NP	I-DNA
LABETALOL	LABETALOL	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
200	200	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
8/10	8/10	CD	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

COZAAR	COZAAR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
LOSARTAN	LOSARTAN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/9	7/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
TRICOR	TRICOR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
108	108	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/24	1/24	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
HUMALOG	HUMALOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ATROVENT	ATROVENT	NNP	I-NP	O
INHALER	INHALER	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
INHALER	INHALER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Gamby	Gamby	NNP	I-NP	O
in	in	IN	B-PP	O
WELLTION	WELLTION	NNP	B-NP	O
HEALTHCARE	HEALTHCARE	NNP	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	SYM	I-NP	O
10	10	CD	I-NP	O
PM	PM	NN	I-NP	O
1/1/03	1/1/03	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Chagolla	Chagolla	NNP	I-NP	O
Urgent	Urgent	NNP	I-NP	O
care	care	NN	I-NP	O
6/17/02	6/17/02	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
shortnes	shortne	NNS	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
not	not	RB	B-NP	O
cardiac	cardiac	JJ	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
IMI	IMI	NNP	I-NP	O
COPD	COPD	NNP	I-NP	O
HYPERCHOLESTEROL	HYPERCHOLESTEROL	NNP	I-NP	O
NIDDM	NIDDM	NNP	I-NP	O
emphysema	emphysema	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66	66	CD	I-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
emphysema	emphysema	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
DMII	DMII	NN	B-NP	B-protein
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
2	2	CD	I-NP	O
month	month	NN	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
desat	desat	VB	I-VP	O
on	on	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
today	today	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
80s	80	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
cath	cath	NN	B-NP	O
with	with	IN	B-PP	O
additionally	additionally	RB	B-ADVP	O
stenting	stente	VBG	B-VP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
MIBI	MIBI	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/26	5/26	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
with	with	IN	B-PP	O
nl	nl	NN	B-NP	B-protein
EF	EF	NN	I-NP	I-protein
and	and	CC	O	O
mild	mild	JJ	B-NP	O
reversible	reversible	JJ	I-NP	O
defects	defect	NNS	I-NP	O
in	in	IN	B-PP	O
peri-infarct	peri-infarct	JJ	B-NP	O
territory	territory	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
until	until	IN	B-PP	O
recently	recently	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
noted	note	VBD	B-VP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
2	2	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
report	report	NN	B-NP	O
PND	PND	NN	I-NP	O
and	and	CC	O	O
new	new	JJ	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

VS	VS	NNS	B-NP	O
:	:	:	O	O
96.6	96.6	CD	B-NP	O
61140/70	61140/70	CD	I-NP	O
24	24	CD	I-NP	O
94	94	CD	I-NP	O
RA	RA	NN	I-NP	O
PEx	PEx	NN	I-NP	O
:	:	:	O	O
Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
bilateral	bilateral	JJ	B-NP	O
basilar	basilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
rrr	rrr	NN	B-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
s1	s1	NN	I-NP	I-protein
and	and	CC	I-NP	O
s2	s2	NN	I-NP	B-protein
,	,	,	O	O
+	+	SYM	B-NP	O
s3	s3	NN	I-NP	O
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
SEM	SEM	NNP	I-NP	O
.	.	.	O	O

Extr	Extr	NN	B-NP	O
:	:	:	O	O
bilateral	bilateral	JJ	B-NP	O
edema	edema	NN	I-NP	O
over	over	IN	B-PP	O
shins	shin	NNS	B-NP	O
,	,	,	O	O
non-pitting	non-pitting	JJ	B-ADJP	O
.	.	.	O	O

Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Dyspnea	Dyspnea	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
includes	include	VBZ	B-VP	O
cardiac	cardiac	JJ	B-NP	O
and	and	CC	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
causes	cause	NNS	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
physical	physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
with	with	IN	B-PP	O
Echo	Echo	NNP	B-NP	O
which	which	WDT	B-NP	O
showd	showd	VBD	B-VP	O
nl	nl	NN	B-NP	B-protein
EF	EF	NN	I-NP	I-protein
and	and	CC	O	O
heart	heart	NN	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Echo	Echo	NNP	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
nl	nl	NN	B-NP	O
RV	RV	NN	I-NP	O
fxn	fxn	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
PE	PE	NN	I-NP	O
and	and	CC	I-NP	O
lung	lung	NN	I-NP	O
parechymal	parechymal	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
CT	CT	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
centrilobular	centrilobular	JJ	I-NP	O
emphysema	emphysema	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
PFTs	PFT	NNS	B-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
lung	lung	NN	B-NP	O
volumes	volume	NNS	I-NP	O
all	all	RB	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
restrictive	restrictive	JJ	I-NP	O
lung	lung	NN	I-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
dilemma	dilemma	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Pulmonary	Pulmonary	JJ	I-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	DT	B-NP	O
doe	doe	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
solely	solely	RB	B-ADVP	O
to	to	TO	B-VP	O
pulm	pulm	VB	I-VP	O
etiologies	etiology	NNS	B-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
desat	desat	NN	B-NP	O
is	be	VBZ	B-VP	O
unexplained	unexplained	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
o2	o2	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
during	during	IN	B-PP	O
exertion	exertion	NN	B-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
Cardiologist	Cardiologist	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Stouch	Stouch	NNP	I-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Hehr	Hehr	NNP	I-NP	O
recommendation	recommendation	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
norvasc	norvasc	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
her	her	PRP$	B-NP	O
atenolol	atenolol	NN	I-NP	O
.	.	.	O	O

Desats	Desat	NNS	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
transient	transient	JJ	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
exertion	exertion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
labetalol	labetalol	NN	B-NP	O
400	400	CD	I-NP	O
bid	bid	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Titrate	Titrate	VB	B-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-SBAR	O
BP	BP	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
3	3	CD	B-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
d/c	d/c	NN	B-NP	O
'd	'd	MD	B-VP	O
on	on	IN	B-PP	O
albuterol	albuterol	NN	B-NP	O
inh	inh	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

F/U	F/U	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
follow-up	follow-up	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
urgent	urgent	NN	B-NP	O
care	care	NN	I-NP	O
next	next	JJ	B-NP	O
wk	wk	NN	I-NP	O
for	for	IN	B-PP	O
re-exam	re-exam	NN	B-NP	O
of	of	IN	B-PP	O
BP	BP	NN	B-NP	O
,	,	,	O	O
volume	volume	NN	B-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
sats	sat	NNS	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
ambulation	ambulation	NN	I-NP	O
.	.	.	O	O

Titrate	Titrate	NN	B-NP	O
labetalol	labetalol	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
persists	persist	VBZ	B-VP	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
desat	desat	VB	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
exertion	exertion	NN	I-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
try	try	VB	I-VP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
DOE	DOE	NNP	B-NP	O
still	still	RB	B-ADVP	O
persists	persist	VBZ	B-VP	O
,	,	,	O	O
consider	consider	VB	B-VP	O
R/L	R/L	NN	B-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
or	or	CC	O	O
cardiopulmonary	cardiopulmonary	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
testing	testing	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
worsening	worsen	VBG	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
call	call	VB	B-VP	O
MD	MD	NNP	B-NP	O
immediately	immediately	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Paasch	Paasch	NNP	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Call	Call	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Fupocyupanqui	Fupocyupanqui	NNP	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
follow-up	follow-up	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Call	Call	NN	B-NP	O
doctors	doctor	NNS	I-NP	O
if	if	IN	B-SBAR	O
symptoms	symptom	NNS	B-NP	O
worsen	worsen	VBN	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
are	be	VBP	B-VP	O
med	me	VBN	I-VP	O
changes	change	NNS	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
stop	stop	NN	I-NP	O
norvasc	norvasc	NN	I-NP	O
-	-	HYPH	O	O
stop	stop	NN	B-NP	O
atenolol	atenolol	NN	I-NP	O
-	-	HYPH	B-NP	O
start	start	NN	I-NP	O
labetalol	labetalol	NN	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
VANVOORHEES	VANVOORHEES	NNP	B-NP	O
,	,	,	O	O
MITCH	MITCH	NNP	B-NP	O
ASHLEY	ASHLEY	NNP	I-NP	O
MARCUS	MARCUS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FH50	FH50	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/11/02	1/11/02	CD	I-NP	O
@	@	NN	I-NP	O
08	08	CD	I-NP	O
:	:	:	O	O
43	43	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

